| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | B |
| 15. Total Score | C7,8,10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | C-terminal cross-linked telopeptide of type I collagen (CTX) |
| Unit | Unknown / _ |
| Overall Analytical Principle Method | Immunoassay; Non-competitive |
| Number of Subjects | 20 |
| Number of Subjects included in BV estimation | 11 |
| Ethinicity | Caucasian |
| Age Mean / Median | 33.0 |
| Age Min | 21.0 |
| Age Max | 45.0 |
| Age SD | |
| Number of Males | |
| Number of Females | 20 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 10 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Day |
| Sampling Times | Start Time:
9:00
End Time: |
| Number of Samples | 5 |
| Average Number of Samples Used for BV Estimation | 5.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 19.1 |
| Calculated Confidence Intervals of CVi | Lower: 15.81, Upper: 24.13 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
| Analytical CV | 1.1 |
| Calculated Confidence Intervals of Analytical CV | Lower: 0.93, Upper: 1.35 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |